ArticleFrontiers in medicine2026

Reclassification of obstetric antiphospholipid syndrome under the 2023 ACR/EULAR criteria: risk of under-recognition in patients with non-criteria antibodies and clinical implications.

Tingwei Sheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.